Potential Drug Treats Fatty Liver Disease in Animal Models, Brings Hope for First Human Treatment

April 10, 2023


Read time:

5-15 mins
Liver Drawing Yellow Bluebackground
Presented by Health Lab

Scientists move one step closer in the battle against fatty liver disease. Researchers at Michigan Medicine developed a glycine-based tripeptide to treat the severe form of fatty liver disease called nonalcoholic steatohepatitis. Researchers hope this discovery is effective in human trials to offset the ever-worldwide spread of the consideration.

More from the Alumni Education Gateway
Join the Alumni Education Gateway Email List​
We use cookies to ensure you get the best experience on our website. By using this site, you accept our use of cookies.